2024 Annual Report update
Sydney, Australia, 4 October 2024: Chimeric Therapeutics (ASX:CHM, “Chimeric” or the
“Company”), notes that the Company’s securities are suspend from trading under Listing Rule
17.5 for the Company not lodging its full year financial statements by 30 September 2024.
The Company advises that the release of its 2024 Annual Report has been delayed pending an
announcement by the Company in relation to a proposed capital raise.
The Company notes that its Appendix 4E and Preliminary Final Report were released on 30 August
2024.
The Company anticipates a further announcement will be made on or before Friday 11 October
2024.
Phillip Hains
Joint Company Secretar
- Forums
- ASX - By Stock
- Ann: 2024 Annual Report update
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

2024 Annual Report updateSydney, Australia, 4 October 2024:...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 243067 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 14771167 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 243067 | 0.004 |
39 | 25597272 | 0.003 |
14 | 13250506 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 14771167 | 22 |
0.006 | 13177711 | 13 |
0.007 | 3200000 | 3 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |